Administering marijuana-derived CBD significantly reduces opioid cravings in animals, according to a new study published in the journal Addiction Neuroscience.
For the study researchers from Washington State University and Legacy Research Institute in Portland examined the efficacy and safety profile of vaporized CBD in female rates. They found that rats provided with CBD were less likely to self-administer morphine.
“The ability of WPE [whole-plant marijuana extract] to reduce opioid reward and drug seeking behavior appears quite robust and of great clinical utility,” states the study.
Continue reading